Literature DB >> 2960821

Structure of low density heparan sulfate proteoglycan isolated from a mouse tumor basement membrane.

M Paulsson1, P D Yurchenco, G C Ruben, J Engel, R Timpl.   

Abstract

A large heparan sulfate proteoglycan of low buoyant density (p = 1.32 to 1.40 g/cm3 in 6 M-guanidine.HCl) was extracted from a tumor basement membrane with denaturing solvents and purified by chromatography and CsCl gradient centrifugation. Chemical, immunological, physical and electron microscopical analyses have demonstrated a high degree of purity and have allowed us to propose a structural model for this proteoglycan. It is composed of an 80 nm long protein core formed from a single polypeptide chain (Mr about 500,000) with intrachain disulfide bonds. This core is folded into a row of six globular domains of variable size as shown by electron microscopy after rotary shadowing and negative staining. A multidomain structure was confirmed by protease digestion experiments that allowed the isolation of a single heparan sulfate-containing peptide segment representing less than 5% of the total mass of the protein core. Electron microscopy has visualized generally three heparan sulfate chains in each molecule close to each other at one pole of the protein core. The molecular mass and length (100 to 170 nm) of the heparan sulfate chains were found to vary consistently between different preparations. The mass per length ratio (350 nm-1) indicated an extended conformation for the heparan sulfate side-chains. These structural features are distinctly different from those of the high density proteoglycan, suggesting that both forms of basement membrane heparan sulfate proteoglycan are genetically distinct and not derived from a common precursor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960821     DOI: 10.1016/0022-2836(87)90125-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

Review 1.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 2.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

3.  Type IV collagen lateral associations in the EHS tumor matrix. Comparison with amniotic and in vitro networks.

Authors:  P D Yurchenco; G C Ruben
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

4.  Isolation and characterization of proteoglycans from human follicular fluid.

Authors:  G V Eriksen; I Carlstedt; M Mörgelin; N Uldbjerg; A Malmström
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.

Authors:  W B Valhmu; G D Palmer; P A Rivers; S Ebara; J F Cheng; S Fischer; A Ratcliffe
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

Review 6.  Proteoglycans of basement membranes.

Authors:  R Timpl
Journal:  Experientia       Date:  1993-05-15

7.  Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix.

Authors:  A D Murdoch; R V Iozzo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver.

Authors:  M Lyon; J T Gallagher
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

10.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.